November 8-10, 2018

San Diego, CA

Missed the live course?
CARPS Self-Study is available now!

Accreditation

CONTINUING MEDICAL EDUCATION 

Nursing Continuing Education
Credit Designation This educational activity for 24.00 contact hours 18 contact hours for the conference sessions and 6 contact hours for the optional hands-on workshops) is provided by Postgraduate Institute for Medicine. 

Accreditation Statements
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. For advance practice nurses, this activity has been submitted for 6.5 contact hours of pharmacotherapy content. Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Global Academy for Medical Education, Inc. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians. 

Physician Credit Designation
The University of Cincinnati designates this Live Activity for a maximum of 24.00 AMA PRA Category 1 Credits, offering 18 AMA PRA Category 1 Credits for the conference sessions and 6 AMA PRA Category 1 Credits for the optional hands-on workshops. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Physician Assistants Credit Designation
The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits from organizations accredited by ACCME

Learning Objectives

Dyslipidemia: Assessment and Treatment of Cardiovascular Risk: Applying 2016 ACC Recommendations
Joyce Ross, MSN, ANP, CLS, CRNP, FPCNA, FNLA

  1. Discuss 2016 Updated ACC Guidelines and NLA Recommendations for Dyslipidemia Management
  2. Recall that statin therapy is the first line medication treatment for risk reduction
  3. Discuss considerations for addition of "other" classes of lipid lowering medication when combination medication therapy is warranted

Your Patient has ACS/AMI: Now What?
Daniel Thomas Thibodeau, MHP, PA-C, DFAAPA

  1. Identify the components within the guidelines of the American College of cardiology and American Heart Association consensus on acute coronary syndrome.
  2. Recognize the importance of dual antiplatelet therapy for those patients recovering from ACS and intervention.
  3. Identify those barriers and challenges that create issues of compliance with patients.
  4. Activate engagement strategies to help patients improve compliance and adherence for acute coronary syndrome in acute myocardial infarction’s.

Enteroendocrine System and Cardio-Pulmonary Health
Christine Kessler, CNS, ANP, BC-ADM, CDTC, FAANP

  1. Describe the bidirectional hormonal and neuropeptide links between the gut and CNS
  2. Discuss how the gut microbiome impacts immunologic functions, lipid metabolism, atherogenesis, glycemic homeostasis, GI function, weight, mentation and mood
  3. Plan a strategy to promote gut health and microbiome stability in order to prevent, or attenuate, selected disease states

Atrial Fibrillation: Choosing Anticoagulation Based on Patient Needs
Mary Ellen Roberts, DNP, RN, APN-C, FAANP, FAAN, FNAP

  1. Assess stroke risk as compared to bleeding risk for anticoagulation in patients with atrial fibrillation.
  2. Communicate the risks and benefits of anticoagulation therapy to patients.
  3. Select appropriate anticoagulation therapy for patients with atrial fibrillation.

Women and Heart Disease: Symptom Recognition & Moving to Care
Leslie L. Davis, PhD, RN, ANP-BC, FAANP, FPCNA, FAHA

  1. Discuss tradition and emerging risk factors that lead to ischemic heart disease (IHD) in women.
  2. Review the pathophysiological differences in IHD in women versus men
  3. Distinguish between typical symptom presentations for women with IHD as compared to those of men
  4. Discuss current recommendations for primary and secondary prevention of IHD in women
  5. Identify four medication classes that are considered "core post-myocardial infarction medications" in order to reduce morbidity and mortality and improve quality of life in women who have had a heart attack
  6. Apply knowledge to case scenarios of women at risk or with IHD

Heart Failure Practical Approaches
Daniel Thomas Thibodeau, MHP, PA-C, DFAAPA

  1. Define the disease of heart failure and its different types
  2. Recognize the general evaluation, workup, and treatment plans
  3. Discuss the practical approaches and challenges when treating heart failure
  4. Recognize newer therapies that are showing promise in the long term outcomes of heart failure

Hypertension: How Low to Go When Treating Older Adults
Leslie L. Davis, PhD, RN, ANP-BC, FAANP, FPCNA, FAHA

  1. Discuss implications of recent clinical practice guidelines of pharmacologic treatment of hypertension (HTN) in adults aged 60 years and older to higher versus lower blood pressure (BP) targets
  2. Determine which of the 4 main classes of pharmacologic agents is/are most appropriate for treating older adults with hypertensive who have common comorbid conditions
  3. Discuss recent research related to internet-based counseling to improve adherence in adults with HTN
  4. Apply knowledge to case scenarios with older adults with HTN

Diabetes Interactive Cases: Clearing Up Some Clinical Conundrums
Christine Kessler, CNS, ANP, BC-ADM, CDTC, FAANP

  1. Analyze and compare AACE & ADA diabetes guidelines with a reality-based, outpatient clinic perspective
  2. Identify appropriate glycemic target goals of patients
  3. Develop a treatment plan for selected patients with varied morbidities using available oral and injectable anti-hyperglycemic medications
  4. Discuss how new and older diabetes medications can be more safely and effectively used together

CKD in HTN: How Should I be Treating it?
Denise Link, MPAS, PA-C

  1. To understand how CKD can lead to secondary and uncontrolled HTN
  2. To appreciate how uncontrolled BP can worsen CKD and albuminuria prognosis
  3. To educate on proper dosing of thiazide, loop and potassium-sparing diuretics based upon level of CKD stage, albuminuria and patient compliance
  4. To illuminate the latest BP guidelines based upon age and comorbidities such as CKD and presence of albuminuria
  5. To illustrate how patient education of their diseases, medications and lifestyle will facilitate in achieving BP management

Cardiology Cases: How Not to Lose your License!
John G. McGinnity, MS, PA-C, DFAAPA

  1. Focus a patient interview and physical examination to assist with the development of a differential diagnosis
  2. Review Cardiac Conditions that may be present with significant consequences if not timely diagnosed
  3. Review the treatment guidelines and latest evidence associated with each condition

COPD: Updated 2016 GOLD Guidelines
Gabriel Ortiz, MPAS, PA-C, DFAAPA

  1. Discuss the updated 2016 GOLD guidelines for COPD
  2. Discuss the prevalence, risk factors and burden of COPD
  3. Describe the diagnosis and prevention of COPD
  4. Explain pharmacologic and non-pharmacologic treatments of COPD

Differentiate Acute Bronchitis and Community Acquired Pneumonia
B. Gwen Carlton, DNP, FNP, AE-C

  1. Assess patients with acute bronchitis and community acquired pneumonia to distinguish between presentations
  2. Treat acute bronchitis and community acquired pneumonia based on the most recent evidence
  3. Educate patients with acute bronchitis and pneumonia regarding their condition, evidence-based treatments, diagnostics, and prevention

Allergic Rhinoconjunctivitis: Diagnostic and Treatment Options
Mary Lou Hayden, RN, MS, FNP-BC, AE-C

  1. Describe presenting signs and symptoms of AR
  2. Discuss evidence based diagnostic tools and treatments

Update on Otitis and Sinusitis
B. Gwen Carlton, DNP, FNP, AE-C

  1. Evaluate patients with otitis and sinusitis to differentiate between chronic and acute presentations and underlying conditions contributing to morbidities
  2. Treat otitis and sinusitis based on the latest research
  3. Educate patients with otitis and sinusitis regarding their condition, evidence based treatments, diagnostics, and referral

Asthma: Comparison of the NHLBI and GINA Guidelines
Gabriel Ortiz, MPAS, PA-C, DFAAPA

  1. Explain the pathophysiology of asthma
  2. Describe the appropriate assessment and classification of asthma
  3. Compare the NIH/NHLBI and GINA guidelines
  4. Discuss the management of asthma as it relates to the asthma guidelines

Severe and Difficult to Treat Asthma: What to do when Asthma is Out of Control
Mary Lou Hayden, RN, MS, FNP-BC, AE-C and Gabriel Ortiz, MPAS, PA-C, DFAAPA

  1. Discuss measures of asthma control
  2. Describe different phenotypes of severe and difficult to control asthma
  3. Discuss evidence-based pharmacologic treatment options for severe and difficult to control asthma.

Smoking Cessation: Helping Patients Quit Smoking and Maintain Abstinence
Wendy L. Wright, MS, RN, ARNP, FNP, FAANP, FAAN

  1. Discuss the current US trends in tobacco use
  2. Apply evidence based guidelines for treating tobacco use and dependence
  3. Compare and contrast newer pharmacologic agents with older agents with regard to benefits, risks, side effects, and drug interactions for treating tobacco dependence

Anaphylaxis: Controversy and Consensus
Mary Lou Hayden, RN, MS, FNP-BC, AE-C

  1. Describe presenting signs and symptoms of anaphylaxis
  2. Discuss appropriate, evidence-based treatment of anaphylaxis

Chronic Cough
Wendy L. Wright, MS, RN, APRN, FNP, FAANP, FAAN

  1. Identify various causes of chronic cough
  2. Discuss the workup for patients with a chronic cough
  3. Discuss treatment options for the patient with a chronic cough

Follow Us

Jointly Provided By

In Association With